Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Patient	O
recorded	O
as	O
having	O
No	O
Known	O
Allergies	O
to	O
Drugs	O
Attending:	O
___	O
Chief	O
Complaint:	O
Palpitations	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
TEE/Cardioversion	O
History	O
of	O
Present	O
Illness:	O
___	O
c	O
relatively	O
little	O
PMH	O
(prostate	O
ca	O
managed	O
conservatively,	O
chronic	O
leg	O
pain)	O
and	O
two	O
prior	O
presentations	O
for	O
atypical	O
cp	O
(once	O
to	O
Dr	O
___	O
in	O
___	O
and	O
once	O
to	O
ED	O
in	O
___	O
p/w	O
___nd	O
palpitations	O
and	O
DOE	O
this	O
afternoon	O
after	O
playing	O
a	O
round	O
of	O
golf	O
this	O
am.	O
Pt	O
denied	O
excessive	O
caffeine	O
or	O
Etoh	O
use.	O
He	O
initially	O
felt	O
like	O
perhaps	O
he	O
had	O
gerd	O
but	O
continued	O
to	O
feel	O
"a	O
little	O
odd"	O
and	O
decided	O
to	O
take	O
his	O
pulse	O
and	O
noted	O
that	O
it	O
was	O
irregular.	O
He	O
thus	O
decided	O
to	O
drive	O
over	O
to	O
the	O
___	O
for	O
further	O
evaluation.	O
His	O
Cp	O
resolved	O
in	O
the	O
ED	O
before	O
he	O
got	O
any	O
meds	O
or	O
had	O
any	O
ekgs.	O
.	O
In	O
ED	O
found	O
to	O
be	O
in	O
afib	O
c	O
rvr	O
150s-180s	O
not	O
hypotensive	O
with	O
ST	O
dep	O
in	O
lateral	O
leads	O
and	O
ST	O
elev	O
in	O
aVR.	O
Pt	O
was	O
given	O
325	O
asa	O
and	O
dilt	O
20IV,	O
25IV	O
dilt	O
and	O
then	O
dilt	O
gtt	O
started	O
at	O
10.	O
Initially	O
pt's	O
bp	O
dropped	O
in	O
setting	O
of	O
dilt	O
drip	O
to	O
___	O
but	O
now	O
in	O
the	O
110s	O
ssytolic.	O
CXR	O
was	O
checked	O
and	O
was	O
unremarkable.	O
VS	O
on	O
admission	O
were	O
97	O
108/57	O
110s	O
16	O
96%	O
RA.	O
Past	O
Medical	O
History:	O
Cardiac	O
Risk	O
Factors:	O
no	O
Diabetes,	O
+	O
Dyslipidemia	O
(not	O
on	O
statin),	O
mild	O
Hypertension	O
(SBP	O
in	O
140s	O
per	O
pt)	O
Other	O
Past	O
History:	O
1.	O
History	O
of	O
gout,	O
last	O
flare	O
___	O
years	O
ago.	O
2.	O
History	O
of	O
prostate	O
cancer,	O
treated	O
with	O
conservative	O
measures	O
and	O
observation.	O
Social	O
History:	O
___	O
Family	O
History:	O
FH	O
is	O
positive	O
for	O
Fa	O
had	O
an	O
MI	O
at	O
age	O
___,	O
died	O
at	O
age	O
___.	O
Mother	O
died	O
suddenly	O
at	O
___.	O
Brother	O
with	O
bypass	O
surgery	O
and	O
shunts.	O
Physical	O
Exam:	O
VS:	O
93.9	O
axillary,	O
140/82,	O
150	O
18	O
92%NC	O
Gen:	O
WDWN	O
elderly	O
male	O
in	O
NAD.	O
Oriented	B-Delirium
x3.	B-Delirium
Mood,	O
affect	O
appropriate.	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
PERRL,	O
EOMI.	O
Conjunctiva	O
were	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
No	O
xanthalesma.	O
Neck:	O
Supple	O
without	O
JVD.	O
CV:	O
RR,	O
normal	O
S1,	O
S2.	O
No	O
m/r/g.	O
No	O
thrills,	O
lifts.	O
No	O
S3	O
or	O
S4.	O
Chest:	O
No	O
chest	O
wall	O
deformities,	O
scoliosis	O
or	O
kyphosis.	O
Resp	O
were	O
unlabored,	O
no	O
accessory	O
muscle	O
use.	O
CTAB,	O
no	O
crackles,	O
wheezes	O
or	O
rhonchi.	O
Abd:	O
Soft,	O
NTND.	O
No	O
HSM	O
or	O
tenderness.	O
Abd	O
aorta	O
not	O
enlarged	O
by	O
palpation.	O
No	O
abdominial	O
bruits.	O
Ext:	O
No	O
c/c/e.	O
No	O
femoral	O
bruits.	O
Skin:	O
No	O
stasis	O
dermatitis,	O
ulcers,	B-Pressure_injury
scars,	O
or	O
xanthomas.	O
.	O
Pulses:	O
Right:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
DP	O
2+	O
___	O
2+	O
Left:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
DP	O
2+	O
___	O
2+	O
Pertinent	O
Results:	O
___	O
08:41PM	O
URINE	O
BLOOD-SM	O
NITRITE-NEG	O
PROTEIN-NEG	O
GLUCOSE-NEG	O
KETONE-NEG	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-5.0	O
LEUK-NEG	O
___	O
03:40PM	O
GLUCOSE-102*	O
UREA	O
N-30*	O
CREAT-1.2	O
SODIUM-139	O
POTASSIUM-4.3	O
CHLORIDE-104	O
TOTAL	O
CO2-24	O
ANION	O
GAP-15	O
___	O
03:40PM	O
cTropnT-LESS	O
THAN	O
___	O
03:40PM	O
CALCIUM-8.3*	O
PHOSPHATE-4.6*	O
MAGNESIUM-2.4	O
___	O
03:40PM	O
TSH-1.6	O
___	O
03:40PM	O
WBC-12.5*#	O
RBC-5.25	O
HGB-15.5	O
HCT-45.6	O
MCV-87	O
MCH-29.5	O
MCHC-34.0	O
RDW-15.0	O
___	O
03:40PM	O
NEUTS-82.8*	O
LYMPHS-12.3*	O
MONOS-3.8	O
EOS-0.9	O
BASOS-0.2	O
___	O
03:40PM	O
___	O
PTT-25.6	O
___	O
EKG:	O
1.	O
Atrial	O
fibrillation	O
with	O
rapid	O
ventricular	O
response.	O
Compared	O
to	O
the	O
previous	O
tracing	O
of	O
___	O
the	O
rate	O
and	O
rhythm	O
have	O
changed.	O
TRACING	O
#1	O
2.	O
Atrial	O
fibrillation	O
with	O
controlled	O
ventricular	O
response.	O
Compared	O
to	O
the	O
previous	O
tracing	O
the	O
rate	O
is	O
slower.	O
TRACING	O
#2	O
Imaging:	O
TTE:	O
The	O
left	O
atrium	O
and	O
right	O
atrium	O
are	O
normal	O
in	O
cavity	O
size.	O
No	O
left	O
atrial	O
mass/thrombus	O
seen	O
(best	O
excluded	O
by	O
transesophageal	O
echocardiography).	O
The	O
right	O
atrial	O
pressure	O
is	O
indeterminate.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size	O
and	O
global	O
systolic	O
function	O
(LVEF>55%).	O
Due	O
to	O
suboptimal	O
technical	O
quality,	O
a	O
focal	O
wall	O
motion	O
abnormality	O
cannot	O
be	O
fully	O
excluded.	O
[Intrinsic	O
left	O
ventricular	O
systolic	O
function	O
is	O
likely	O
more	O
depressed	O
given	O
the	O
severity	O
of	O
valvular	O
regurgitation.]	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
aortic	O
root	O
is	O
mildly	O
dilated	O
at	O
the	O
sinus	O
level.	O
The	O
ascending	O
aorta	O
is	O
mildly	O
dilated.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened.	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
Moderate	O
(2+)	O
mitral	O
regurgitation	O
is	O
seen.	O
The	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
high	O
normal.	O
Significant	O
pulmonic	O
regurgitation	O
is	O
seen.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
Suboptimal	O
image	O
quality.	O
Mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
preserved	O
global	O
biventricular	O
systolic	O
function.	O
Moderate	O
mitral	O
regurgitation.	O
Dilated	O
ascending	O
aorta.	O
Aortic	O
valve	O
sclerosis.	O
TEE:	O
The	O
left	O
atrium	O
and	O
right	O
atrium	O
are	O
normal	O
in	O
cavity	O
size.	O
No	O
spontaneous	O
echo	O
contrast	O
or	O
thrombus	O
is	O
seen	O
in	O
the	O
body	O
of	O
the	O
left	O
atrium/left	O
atrial	O
appendage	O
or	O
the	O
body	O
of	O
the	O
right	O
atrium/right	O
atrial	O
appendage.	O
Left	O
atrial	O
appendage	O
ejection	O
velocities	O
are	O
vigorous	O
(>0.4m/s).	O
A	O
small,	O
intermittent	O
left-to-right	O
shunt	O
across	O
the	O
interatrial	O
septum	O
is	O
seen	O
at	O
rest	O
consistent	O
with	O
color	O
flow	O
Doppler	O
c/w	O
a	O
small	O
secundum	O
atrial	O
septal	O
defect/stretched	O
PFO.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(LVEF>55%).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
There	O
are	O
simple	O
atheroma	O
in	O
the	O
ascending	O
aorta,	O
aortic	O
arch,	O
and	O
descending	O
thoracic	O
aorta.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened.	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Moderate	O
(2+)	O
mitral	O
regurgitation	O
is	O
seen.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
No	O
left	O
atrial/appendage	O
thrombus	O
seen.	O
Small	O
secundum	O
atrial	O
septal	O
defect.	O
Moderate	O
mitral	O
regurgitation.	O
CXR:	O
IMPRESSION:	O
Subsegmental	O
atelectasis,	O
otherwise	O
no	O
acute	O
cardiopulmonary	O
disease.	O
Brief	O
Hospital	O
Course:	O
___	O
c	O
relatively	O
little	O
PMH	O
p/w	O
presumed	O
new	O
onset	O
atrial	O
fibrillation,	O
though	O
hard	O
to	O
know	O
as	O
pt	O
was	O
prompted	O
to	O
check	O
his	O
pulse	O
based	O
on	O
chest	O
pressure	O
which	O
could	O
be	O
___nd	O
atrial	O
fibrillation	O
that	O
is	O
older.	O
CAD:	O
No	O
known	O
CAD.	O
Pump:	O
Normal	O
Rhythm:	O
Presumed	O
new	O
onset	O
afib	O
with	O
RVR.	O
Unclear	O
etiology.	O
TSH	O
was	O
wnl.	O
Left	O
atrial	O
chambers	O
within	O
normal	O
limits.	O
___	O
complete.	O
No	O
infectious	O
etiology	O
found.	O
He	O
was	O
started	O
on	O
coumadin	O
with	O
a	O
heparin	O
bridge.	O
Patient's	O
heart	O
rate	O
was	O
controlled	O
on	O
diltizem	O
drip	O
and	O
was	O
transitioned	O
to	O
po	O
metoprolol.	O
Since	O
he	O
did	O
not	O
convert	O
into	O
sinus	O
rhythm,	O
he	O
was	O
TEE/Cardioverted	O
with	O
good	O
effect.	O
He	O
remained	O
in	O
sinus	O
rhythm	O
and	O
was	O
discharged	O
on	O
Metoprolol	O
succinate	O
50	O
mg	O
daily	O
with	O
close	O
follow	O
up	O
in	O
the	O
outpatient	O
with	O
cardiology.	O
He	O
was	O
sent	O
home	O
with	O
lovenox	O
injections	O
to	O
bridge	O
to	O
coumadin	O
for	O
INR	O
goal	O
of	O
___.	O
He	O
has	O
close	O
follow	O
up	O
with	O
his	O
pcp	O
for	O
further	O
___	O
of	O
his	O
coumadin.	O
Elevated	O
WBC	O
count:	O
Mildly	O
elevated	O
to	O
12.7.	O
Infectious	O
work	O
up	O
negative.	O
Differential	O
with	O
a	O
left	O
shift.	O
Repeat	O
white	O
blood	O
cell	O
count	O
should	O
be	O
performed	O
in	O
the	O
outpatient.	O
Hematuria:	O
Mild	O
amount	O
of	O
blood	O
noted	O
in	O
urine.	O
Urine	O
culture	O
negative.	O
Repeat	O
UA	O
should	O
be	O
performed	O
in	O
the	O
outpatient	O
to	O
ensure	O
this	O
has	O
resolved.	O
Chronic	O
Kidney	O
Disease:	O
Pt	O
has	O
mildly	O
decreased	O
GFR,	O
likley	O
stage	O
3	O
ckd.	O
Patient	O
was	O
advised	O
to	O
stop	O
taking	O
ibuoprofen,	O
as	O
he	O
was	O
taking	O
this	O
on	O
a	O
regular	O
basis.	O
Further	O
management	O
will	O
be	O
deferred	O
to	O
outpatient.	O
Prostate	O
ca:	O
Stable	O
during	O
admission.	O
Leg	O
pain:	O
Continued	O
tylenol	O
prn.	O
Held	O
ibuprofen	O
as	O
above.	O
Gout:	O
Renally	O
dosed	O
allopurinol	O
and	O
discharged	O
on	O
reduced	O
dose.	O
Code:	O
DNR/DNI	O
during	O
this	O
admission	O
Medications	O
on	O
Admission:	O
1.	O
Tylenol.	O
2.	O
Advil.	O
3.	O
Arnica.	O
4.	O
Allopurinol.	O
5.	O
Multivitamin.	O
6.	O
Saw	O
___.	O
7.	O
occasional	O
ambien	O
Discharge	O
Medications:	O
1.	O
Lovenox	O
___	O
mg/mL	O
Syringe	O
Sig:	O
One	O
(1)	O
Subcutaneous	O
once	O
a	O
day	O
for	O
3	O
days.	O
Disp:*3	O
1*	O
Refills:*0*	O
2.	O
Allopurinol	O
___	O
mg	O
Tablet	O
Sig:	O
1.5	O
Tablets	O
PO	O
DAILY	O
(Daily).	O
3.	O
Warfarin	O
2.5	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
once	O
a	O
day.	O
Disp:*60	O
Tablet(s)*	O
Refills:*2*	O
4.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
every	O
six	O
(6)	O
hours	O
as	O
needed	O
for	O
pain:	O
do	O
not	O
exceed	O
4	O
gram	O
in	O
24	O
hours.	O
5.	O
Multivitamin	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
6.	O
Metoprolol	O
Succinate	O
50	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
PO	O
once	O
a	O
day.	O
Disp:*30	O
Tablet	O
Sustained	O
Release	O
24	O
hr(s)*	O
Refills:*2*	O
7.	O
Outpatient	O
Lab	O
Work	O
INR	O
check:	O
___	O
and	O
send	O
results	O
to	O
Ms.	O
___,	O
Nurse	O
___.	O
Her	O
phone	O
number	O
is	O
___.	O
8.	O
Saw	O
___	O
Oral	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary:	O
Atrial	O
Fibrillation	O
with	O
Rapid	O
Ventricular	O
Response	O
Secondary:	O
Prostate	O
Cancer	O
Gout	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
because	O
of	O
a	O
fast	O
heart	O
rate	O
and	O
an	O
irregular	O
rhythm	O
called	O
atrial	O
fibrillation.	O
You	O
were	O
cardioverted	O
back	O
to	O
a	O
regular	O
rhythm.	O
You	O
will	O
need	O
to	O
stay	O
on	O
blood	O
thinners	O
for	O
at	O
least	O
one	O
month	O
and	O
have	O
close	O
follow	O
up	O
with	O
your	O
primary	O
care	O
doctor.	O
You	O
were	O
also	O
started	O
on	O
a	O
medication	O
to	O
slow	O
your	O
heart	O
rate	O
called	O
metoprolol.	O
You	O
should	O
continue	O
all	O
of	O
your	O
medications	O
as	O
prescribed	O
with	O
the	O
following	O
important	O
changes:	O
1.	O
Warfarin	O
5	O
mg	O
daily	O
(you	O
will	O
have	O
further	O
instruction	O
from	O
your	O
primary	O
care	O
doctor's	O
office	O
as	O
this	O
dose	O
may	O
change)	O
2.	O
Lovenox	O
___	O
mg	O
syringe	O
daily	O
until	O
your	O
coumadin	O
level	O
is	O
therapeutic.	O
Your	O
primary	O
care	O
doctor's	O
office	O
should	O
direct	O
how	O
many	O
days	O
to	O
take	O
this	O
medication.	O
3.	O
Metoprolol	O
Succinate	O
50	O
mg	O
daily	O
4.	O
DECREASE	O
Allopurinol	O
to	O
150	O
mg	O
daily	O
(this	O
was	O
decreased	O
based	O
on	O
your	O
kidney	O
function)	O
5.	O
STOP	O
Ibuprofen	O
given	O
your	O
depressed	O
kidney	O
function	O
6.	O
STOP	O
Ambien	O
because	O
you	O
were	O
mildly	O
confused	O
overnight	O
and	O
this	O
medication	O
You	O
will	O
need	O
to	O
follow	O
closely	O
with	O
your	O
PCP	O
for	O
coumadin/INR	O
checks	O
to	O
ensure	O
you	O
are	O
taking	O
the	O
appropriate	O
dosage.	O
It	O
is	O
important	O
that	O
you	O
keep	O
all	O
of	O
your	O
doctor's	O
appointments.	O
It	O
is	O
important	O
that	O
you	O
keep	O
all	O
of	O
your	O
doctor's	O
appointments.	O
Followup	O
Instructions:	O
___	O

